ask="1.22"
ask_size="9000"
average_daily_volume="886105"
bid="1.16"
bid_size="8800"
book_value="0.61"
change="-0.09"
change_from_200_day_moving_average="0.07"
change_from_50_day_moving_average="0.40"
change_from_52_week_high="-3.12"
change_From_52_week_low="0.58"
change_in_percent="-6.92%"
close="1.21"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.65"
ebitda="-42.12M"
eps_estimate_current_year="-1.50"
eps_estimate_next_quarter="-0.31"
eps_estimate_next_year="-1.45"
ex_dividend_date="N/A"
float_shares="15676000"
high="1.49"
high_52_weeks="4.33"
last_trade_date="2/6/2017"
last_trade_price="1.21"
last_trade_size="200"
last_trade_time="4:00pm"
low="1.12"
low_52_weeks="0.63"
market_capitalization="33.20M"
moving_average_200_day="1.14"
moving_average_50_day="0.81"
name="Cerulean Pharma Inc."
notes="N/A"
one_year_target_price="5.50"
open="1.44"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+5.88%"
percent_change_from_50_day_moving_average="+48.55%"
percent_change_from_52_week_high="-72.06%"
percent_change_from_52_week_low="+92.06%"
previous_close="1.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.14"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="27435000"
short_ratio="1.70"
stock_exchange="NGM"
symbol="CERU"
volume="8650963"
weeks_range_52="0.63 - 4.33"
